South Africa agrees to human trials of potential COVID-19 vaccine

South Africa has agreed to take part in the human trials of potential vaccine against the novel coronavirus.

The decision makes South Africa the African continent’s first country, and the world’s second country outside of Britain, after Brazil, to agree to take part in the Oxford University vaccine trial. Brazil has begun with the COVID-19 vaccine trial on June 24.

Oxford University scientists, who developed the vaccine, also known as AZD1222, are working with AstraZeneca on development and production.

On June 24, Oxford University in conjunction with South Africa’s University of the Witwatersrand, has announced thousands of volunteers between the ages of 18 and 65 who received the vaccination will be monitored for 12 months to see how well the vaccine guards against COVID-19.     

South Africa has been witnessing a continuous surge in the COVID-19 cases post the gradual easing of the coronavirus lockdown measures and accounts for the highest rate of infections in the Africa continent.

Photo Credit :

Comments are closed, but trackbacks and pingbacks are open.